Defects in Innate and Intrinsic Immunity in Morocco: A Retrospective Analysis of the Genetic Landscape and Clinical Correlations
Article Sidebar
Main Article Content
Abstract
Background: Susceptibility to common infectious diseases is often linked to innate immune deficiencies. Patients may present normal standard immunological profiles but remain highly vulnerable to infections, complicating diagnosis. This study investigates innate and intrinsic immune deficiencies and their genetic underpinnings in Moroccan patients, emphasizing early detection and personalized care.
Methods: A retrospective analysis was conducted using data from the Moroccan Inborn Errors of Immunity (IEI) registry (2008–2024). Included were patients with confirmed innate or intrinsic immunodeficiencies based on CBC, CRP, immunoglobulin levels, lymphocyte subpopulations, and whole-exome sequencing. Classification followed the 2022 IUIS criteria.
Results: Among 884 patients with IEI, 79 (~9%) had innate or intrinsic immunodeficiencies, with genetic confirmation in 46 (58%). Of these, 23 (50%) were diagnosed with Mendelian susceptibility to mycobacterial disease (MSMD), involving mutations in the IL12RB1, STAT1, IFNGR1, SPPL2A, TYK2, and TBX21 (T-bet) genes. Chronic mucocutaneous candidiasis (CMC) was found in 15 (32%) patients, linked to STAT1 and IL17RA mutations. Severe viral infection predisposition was seen in 3 patients (POLR3A, IFIH1, TLR7XL) and bacterial susceptibility in 3 others (IRF4, IFNGR1, NCSTN). Novel variants were identified, including IRAK4 c.277delT (p.F93fsX26), not previously reported, and SNORA31 (n.36T>C), previously seen in Saudi Arabia, now found in a Moroccan case of herpes simplex encephalitis.
Conclusion: This study reveals the genetic complexity of innate immune disorders in Morocco, with a notable prevalence of MSMD and CMC. It underscores the value of early genetic screening to guide diagnosis and improve patient outcomes.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Pathogens and Immunity abides by Creative Commons BY 4.0:
http://creativecommons.org/licenses/by/4.0/
This license lets others distribute, remix, tweak, and build upon your work for any lawful purpose, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. The authors maintain copyright of their materal.
*Due to a template error on our pdfs, articles published from May 20, 2016 to June 24, 2022 incorrectly state the copyright is held by Pathogens and Immunity. Copyright of all articles is held by the authors of each article as noted in the above copyright policy.
References
1. Fischer S, Deindl E. State of the Art of Innate Immunity-An Overview. Cells. 2022;11(17):2705. doi: 10.3390/cells11172705. PubMed PMID: 36078113; PMCID: PMC9454720.
2. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009;22(2):240-73, Table of Contents. doi: 10.1128/CMR.00046-08. PubMed PMID: 19366914; PMCID: PMC2668232.
3. Brubaker SW, Bonham KS, Zanoni I, Kagan JC. Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol. 2015;33:257-90. doi: 10.1146/annurev-immunol-032414-112240. PubMed PMID: 25581309; PMCID: PMC5146691.
4. Refaat M, Oujane C, Kholaiq H, Aadam Z, Errami A, Baghad B, Boussetta S, El Kettani A, Benhsaien I, Ailal F, Bourhanbour AD, El Bakkouri J, Bousfiha AA. Innate immunodeficiencies: a group of primary immunodeficiencies predisposing exclusively to common diseases. Egyptian Journal of Medical Human Genetics. 2024;25(1):134. doi: 10.1186/s43042-024-00604-4.
5. Rey-Jurado E, Poli MC. Functional Genetics in Inborn Errors of Immunity. Future Rare Diseases. 2021;1(2):FRD11. doi: 10.2217/frd-2020-0003.
6. Grumach AS, Goudouris ES. Inborn Errors of Immunity: how to diagnose them? J Pediatr (Rio J). 2021;97 Suppl 1(Suppl 1):S84-S90. doi: . PubMed PMID: 33400918; PMCID: PMC9432000.
7. Pieniawska-Smiech K, Pasternak G, Lewandowicz-Uszynska A, Jutel M. Diagnostic Challenges in Patients with Inborn Errors of Immunity with Different Manifestations of Immune Dysregulation. J Clin Med. 2022;11(14):4220. doi: 10.3390/jcm11144220. PubMed PMID: 35887984; PMCID: PMC9324612.
8. Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, Rundles CC, Franco JL, Holland SM, Klein C, Morio T, Oksenhendler E, Puel A, Puck J, Seppanen MRJ, Somech R, Su HC, Sullivan KE, Torgerson TR, Meyts I. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. J Clin Immunol. 2022;42(7):1508-20. doi: 10.1007/s10875-022-01352-z. PubMed PMID: 36198931.
9. Rasouli SE, Tavakol M, Sadri H, Chavoshzadeh Z, Alireza Mahdaviani S, Delavari S, Jamee M, Kalantari A, Seifi Alan M, Aghamahdi F, Abolhassani H, Yazdani R, Rezaei N, Azizi G. The spectrum of inborn errors of immunity: a single tertiary center retrospective study in Alborz, Iran. Eur Ann Allergy Clin Immunol. 2023;55(1):19-28. doi: 10.23822/EurAnnACI.1764-1489.239. PubMed PMID: 34918886.
10. Aghamohammadi A, Rezaei N, Yazdani R, Delavari S, Kutukculer N, Topyildiz E, Ozen A, Baris S, Karakoc-Aydiner E, Kilic SS, Kose H, Gulez N, Genel F, Reisli I, Djenouhat K, Tahiat A, Boukari R, Ladj S, Belbouab R, Ferhani Y, Belaid B, Djidjik R, Kechout N, Attal N, Saidani K, Barbouche R, Bousfiha A, Sobh A, Rizk R, Elnagdy MH, Al-Ahmed M, Al-Tamemi S, Nasrullayeva G, Adeli M, Al-Nesf M, Hassen A, Mehawej C, Irani C, Megarbane A, Quinn J, Group M-IEIS, Marodi L, Modell V, Modell F, Al-Herz W, Geha RS, Abolhassani H. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity. J Clin Immunol. 2021;41(6):1339-51. doi: 10.1007/s10875-021-01053-z. PubMed PMID: 34052995; PMCID: PMC8310844.
11. Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, Klein C, Morio T, Oksenhendler E, Picard C, Puel A, Puck J, Seppanen MRJ, Somech R, Su HC, Sullivan KE, Torgerson TR, Meyts I. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473-507. doi: 10.1007/s10875-022-01289-3. PubMed PMID: 35748970; PMCID: PMC9244088.
12. Alsina L, Rodriguez-Gallego C, Esteve-Solé A, Vlagea A, Pérez de Diego R, Martínez-Barricarte R, Deyà-Martínez À. Defects in Intrinsic and Innate Immunity. In: D’Elios MM, Baldari CT, Annunziato F, editors. Cellular Primary Immunodeficiencies. Cham: Springer International Publishing; 2021. p. 177-212.
13. Errami A, Baghdadi JE, Ailal F, Benhsaien I, Bakkouri JE, Jeddane L, Rada N, Benajiba N, Mokhantar K, Ouazahrou K, Zaidi S, Abel L, Casanova JL, Boisson-Dupuis S, Bustamante J, Bousfiha AA. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds. J Clin Immunol. 2023;43(4):728-40. doi: 10.1007/s10875-022-01419-x. PubMed PMID: 36630059; PMCID: PMC10121882.
14. Wu J, Zhong W, Yin Y, Zhang H. Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center. BMC Pediatr. 2019;19(1):410. doi: 10.1186/s12887-019-1729-7. PubMed PMID: 31684895; PMCID: PMC6829960.
15. Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009;29(3):343-51. doi: 10.1007/s10875-008-9260-x. PubMed PMID: 19002574.
16. Mahlaoui N, Picard C, Bach P, Costes L, Courteille V, Ranohavimparany A, Alcais A, Jais JP, Fischer A, group CFPs. Genetic diagnosis of primary immunodeficiencies: A survey of the French national registry. J Allergy Clin Immunol. 2019;143(4):1646-9 e10. doi: 10.1016/j.jaci.2018.12.994. PubMed PMID: 30639347.
17. Barbouche MR, Mekki N, Ben-Ali M, Ben-Mustapha I. Lessons from Genetic Studies of Primary Immunodeficiencies in a Highly Consanguineous Population. Front Immunol. 2017;8:737. doi: 10.3389/fimmu.2017.00737. PubMed PMID: 28702026; PMCID: PMC5485821.
18. Sobh A, Mosad D, Zeid M, Salem O, Elnagdy M, El-Hadidy N, Bahgat S, Rizk R, Geha R. Clinical and Genetic Characteristics of Children with Inborn Errors of Immunity from Egypt: A single Centre Study2022.
19. Baghad B, Bousfiha AA, Chiheb S, Ailal F. [Genetic predisposition to mucocutaneous fungal infections]. Rev Med Interne. 2021;42(8):566-70. doi: 10.1016/j.revmed.2021.05.009. PubMed PMID: 34052048.
20. Lafaille FG, Harschnitz O, Lee YS, Zhang P, Hasek ML, Kerner G, Itan Y, Ewaleifoh O, Rapaport F, Carlile TM, Carter-Timofte ME, Paquet D, Dobbs K, Zimmer B, Gao D, Rojas-Duran MF, Kwart D, Rattina V, Ciancanelli MJ, McAlpine JL, Lorenzo L, Boucherit S, Rozenberg F, Halwani R, Henry B, Amenzoui N, Alsum Z, Marques L, Church JA, Al-Muhsen S, Tardieu M, Bousfiha AA, Paludan SR, Mogensen TH, Quintana-Murci L, Tessier-Lavigne M, Smith GA, Notarangelo LD, Studer L, Gilbert W, Abel L, Casanova JL, Zhang SY. Human SNORA31 variations impair cortical neuron-intrinsic immunity to HSV-1 and underlie herpes simplex encephalitis. Nat Med. 2019;25(12):1873-84. doi: 10.1038/s41591-019-0672-3. PubMed PMID: 31806906; PMCID: PMC7376819.
21. Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, Chrabieh M, Issekutz AC, Cunningham CK, Gallin J, Holland SM, Roifman C, Ehl S, Smart J, Tang M, Barrat FJ, Levy O, McDonald D, Day-Good NK, Miller R, Takada H, Hara T, Al-Hajjar S, Al-Ghonaium A, Speert D, Sanlaville D, Li X, Geissmann F, Vivier E, Marodi L, Garty BZ, Chapel H, Rodriguez-Gallego C, Bossuyt X, Abel L, Puel A, Casanova JL. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med. 2007;204(10):2407-22. doi: 10.1084/jem.20070628. PubMed PMID: 17893200; PMCID: PMC2118442.